These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7057421)

  • 1. A comparison of the inhibition of growth of methotrexate-resistant and -sensitive leukemia cells in culture by triazines. Evidence for a new mechanism of cell resistance to methotrexate.
    Selassie CD; Guo Z; Hansch C; Khwaja TA; Pentecost S
    J Med Chem; 1982 Feb; 25(2):157-61. PubMed ID: 7057421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydrofolate reductase inhibition. A study in the use of X-ray crystallography, molecular graphics, and quantitative structure-activity relations in drug design.
    Hansch C
    Drug Intell Clin Pharm; 1982 May; 16(5):391-6. PubMed ID: 6806055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative structure-activity relationships of antifolate triazines inhibiting murine tumor cells sensitive and resistant to methotrexate.
    Selassie CD; Hansch C; Khwaja TA; Dias CB; Pentecost S
    J Med Chem; 1984 Mar; 27(3):347-57. PubMed ID: 6699880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of a methotrexate-insensitive dihydrofolate reductase from L5178Y cells by substituted triazines and quinazolines.
    Dedhar S; Freisheim JH; Hynes JB; Goldie JH
    Biochem Pharmacol; 1983 Mar; 32(5):922-4. PubMed ID: 6838639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the inhibition of methotrexate-sensitive and -resistant Lactobacillus casei cell cultures with purified Lactobacillus casei dihydrofolate reductase by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(3-substituted-phenyl)-s-triazines. Use of quantitative structure-activity relationships in making inferences about the mechanism of resistance and the structure of the enzyme is situ compared with the enzyme in vitro.
    Coats EA; Genther CS; Dietrich SW; Guo ZR; Hansch C
    J Med Chem; 1981 Dec; 24(12):1422-9. PubMed ID: 6796688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of triazines as inhibitors of L1210 dihydrofolate reductase and of L1210 cells sensitive and resistant to methotrexate.
    Selassie CD; Strong CD; Hansch C; Delcamp TJ; Freisheim JH; Khwaja TA
    Cancer Res; 1986 Feb; 46(2):744-56. PubMed ID: 3940640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative structure-activity relationship of antifolate inhibition of bacteria cell cultures resistant and sensitive to methotrexate.
    Coats EA; Genther CS; Selassie CD; Strong CD; Hansch C
    J Med Chem; 1985 Dec; 28(12):1910-6. PubMed ID: 3934385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further studies on substituted quinazolines and triazines as inhibitors of a methotrexate-insensitive murine dihydrofolate reductase.
    Dedhar S; Freisheim JH; Hynes JB; Goldie JH
    Biochem Pharmacol; 1986 Apr; 35(7):1143-7. PubMed ID: 3964294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human dihydrofolate reductase by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(substituted-phenyl)-s-triazine s. A quantitative structure-activity relationship analysis.
    Hathaway BA; Guo ZR; Hansch C; Delcamp TJ; Susten SS; Freisheim JH
    J Med Chem; 1984 Feb; 27(2):144-9. PubMed ID: 6694162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative structure-activity relationship of triazine-antifolate inhibition of Leishmania dihydrofolate reductase and cell growth.
    Booth RG; Selassie CD; Hansch C; Santi DV
    J Med Chem; 1987 Jul; 30(7):1218-24. PubMed ID: 3599028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate analogues. 34. Replacement of the glutamate moiety in methotrexate and aminopterin by long-chain 2-aminoalkanedioic acids.
    Rosowsky A; Bader H; Kohler W; Freisheim JH; Moran RG
    J Med Chem; 1988 Jul; 31(7):1338-44. PubMed ID: 2898531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies concerned with overcoming resistance to methotrexate: a comparison of the effects of methotrexate and 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine (BW50197) on the colony forming ability of L5178Y cells.
    Hill BT; Goldie JH; Price LA
    Br J Cancer; 1973 Sep; 28(3):263-8. PubMed ID: 4743908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the inhibition of bovine and murine leukemia dihydrofolate reductase by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(3-X-phenyl)-s-triazines.
    Guo ZR; Dietrich SW; Hansch C; Dolnick BJ; Bertino JR
    Mol Pharmacol; 1981 Nov; 20(3):649-56. PubMed ID: 7329407
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition by 5-(substituted-benzyl)-2,4-diaminopyrimidines of murine tumor (L5178Y) cell cultures sensitive to and resistant to methotrexate. Further evidence for the sensitivity of resistant cells to hydrophobic drugs.
    Selassie CD; Li R; Hansch C; Khwaja TA; Dias CB
    J Med Chem; 1982 May; 25(5):518-22. PubMed ID: 7086836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydrofolate reductase activity in adriamycin and methotrexate sensitive and resistant P388 leukemia cells.
    Mandelbaum-Shavit F; Ramu A
    Cell Biol Int Rep; 1987 May; 11(5):389-96. PubMed ID: 3607890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of DNA synthesis in normal and malignant human cells by triazinate (Baker's antifol) and methotrexate.
    Skeel RT; Sawicki WL; Cashmore AR; Bertino JR
    Cancer Res; 1976 Oct; 36(10):3659-64. PubMed ID: 953990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of quantitative structure-activity relationships of the inhibition of leukemia cells in culture with the inhibition of dihydrofolate reductase from leukemia cells and other cell types.
    Khwaja TA; Pentecost S; Selassie CD; Guo Z; Hansch C
    J Med Chem; 1982 Feb; 25(2):153-6. PubMed ID: 7057420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists.
    Ohnoshi T; Ohnuma T; Takahashi I; Scanlon K; Kamen BA; Holland JF
    Cancer Res; 1982 May; 42(5):1655-60. PubMed ID: 6978176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate analogues. 30. Dihydrofolate reductase inhibition and in vitro tumor cell growth inhibition by N epsilon-(haloacetyl)-L-lysine and N delta-(haloacetyl)-L-ornithine analogues and an acivicin analogue of methotrexate.
    Rosowsky A; Solan VC; Forsch RA; Delcamp TJ; Baccanari DP; Freisheim JH
    J Med Chem; 1987 Aug; 30(8):1463-9. PubMed ID: 3112397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syntheses and antifolate activity of 5-methyl-5-deaza analogues of aminopterin, methotrexate, folic acid, and N10-methylfolic acid.
    Piper JR; McCaleb GS; Montgomery JA; Kisliuk RL; Gaumont Y; Sirotnak FM
    J Med Chem; 1986 Jun; 29(6):1080-7. PubMed ID: 2423690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.